SERASera Prognostics, Inc.
2.150USD+3.86%Mkt Cap: 87.32M USDP/E: Last update: 2026-05-26

Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM t…

Indicators:|

Key Statistics

Company
Market Cap87.32M USD
Enterprise Value25.59M USD
Revenue (TTM)57.00K USD
Gross Profit-83.00K USD
Net Income (TTM)-31.93M USD
Revenue/Share0.0010 USD
Last Price2.150 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees71
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-2.63
PEG
EV/EBITDA-0.71
EV/Revenue448.94
P/S1236.59
P/B0.93
EPS (TTM)-0.64
EPS (Forward)-0.69
52W Range
1.37029% of range4.090
52W High4.090 USD
52W Low1.370 USD
Profitability
Gross Margin-102.47%
Oper. Margin-66857.14%
EBITDA Margin0.00%
Profit Margin-39417.28%
ROE-42.34%
ROA-31.32%
Growth
Revenue Growth-63.20%
Earnings Growth
Cash Flow & Leverage
Operating CF-25.62M USD
CapEx (TTM)726.00K USD
FCF Margin-33163.38%
FCF Yield-21.65%
Net Debt-44.90M USD
Net Debt/EBITDA1.25
Balance Sheet
Debt/Equity0.03
Current Ratio2.12
Quick Ratio2.02
Book Value/Sh1.936 USD
Cash/Share1.210 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)5.000 USD
Target Range5.000 USD5.000 USD
# Analysts1
Ownership
Shares Out.38.19M
Float27.58M
Insiders11.68%
Institutions63.32%
Short Interest
Short Ratio11.8d
Short % Float0.96%
Short % Out.0.76%
Shares Short298.29K
Short (prev mo.)381.49K
Technical
SMA 501.976 (+8.8%)
SMA 2002.736 (-21.4%)
Beta0.93
S&P 52W Chg28.31%
Avg Vol (30d)57.73K
Avg Vol (10d)65.68K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)